ArticleArthritis research & therapy2026
Gender differences in the clinical features and quality of life of Japanese patients with systemic lupus erythematosus: a cross-sectional study based on the LUNA registry.
Article in Arthritis research & therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
29 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGender differences in clinical manifestations and disease progression of systemic lupus erythematosus (SLE) have been well documented; however, there is a paucity of literature on the gender differences in the quality of life (QOL) of patients with SLE, especially in the context of organ-specific damage. This study aimed to explore gender differences in the clinical features and patient-reported outcomes among Japanese patients with SLE, with particular focus on the effect of joint and cardiac damage on gender-based disparities in QOL: previous studies have shown that articular and cardiac damage are associated with impaired health-related HR QOL (HRQOL).
methodsIn this retrospective, cross-sectional multicenter cohort study, we used data from 1297 Japanese patients with SLE (159 males (12.3%) and 1138 females (87.7%)) enrolled in a nationwide multicenter registry (LUNA), and compared the clinical variables, organ damage scores (SLICC/ACR Damage Index [SDI]), and QOL (assessed using the LupusPRO questionnaire) between the sexes. Additionally, subgroup analyses were performed for patients with arthritis/joint damage, cardiac damage, and according to disease activity (lupus low disease activity state, LLDAS).
resultsThe median age of our cohort was 51 years (interquartile range, 40-63 years). Male patients had a shorter disease duration and were older at disease onset than females. The disease activity scores were slightly lower in male patients, whereas SDI was slightly higher in females. Male patients exhibited lower rates of articular/joint damage (1.26% versus 4.66%, p = 0.046) but higher rates of cardiac damage (11.3% versus 7.15%, p = 0.015) than females. The LupusPRO indicated higher HRQOL scores for male patients with SLE than female patients (87.4 versus 80.5, p = 0.001); however, the difference of HRQOL became unclear between both sexes in the presence of arthritis/joint damage and cardiac damage.
conclusionJapanese male patients with SLE have a relatively higher HRQOL than females; however, this change became unclear in patients with SLE who had joint or cardiac damage. Further investigations are needed to clarify exact contributing factors for better HRQOL in male patients with SLE.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.